Abiopharma

Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates

Crescent Biopharma to Present at November Investor Conferences

Vera Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

Cardiol Therapeutics’ Phase II ARCHER Trial Results to be Presented at the European Society of Cardiology Scientific Meeting on Myocardial & Pericardial Diseases

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

The Joint Corp. Board of Directors Authorizes an Additional $12 Million for Stock Repurchase Program

Anika Reports Third Quarter 2025 Financial Results

Celcuity Inc. Schedules Release of Third Quarter 2025 Financial Results and Webcast/Conference Call

Charles River Laboratories Provides Update on Strategic Review